Deubiquitinating Enzymes as Therapeutic Targets in Cancer

E-ISSN： 1873-4286|19|22|4039-4052

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.22, 2013-07, pp. : 4039-4052

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Deubiquitinating Enzymes as Promising Drug Targets for Infectious Diseases

Current Pharmaceutical Design, Vol. 19, Iss. 18, 2013-06 ,pp. : 3234-3247

Bentham Science Publishers

Access to resources Recommend Favorite

Topoisomerase Enzymes as Therapeutic Targets for Cancer Chemotherapy

Medicinal Chemistry, Vol. 1, Iss. 4, 2005-06 ,pp. : 383-394

Bentham Science Publishers

Access to resources Recommend Favorite

Secreted phospholipase A₂ enzymes as therapeutic targets

By Scott Kieran F Graham Garry G Bryant Katherine J

Expert Opinion on Therapeutic Targets, Vol. 7, Iss. 3, 2003-06 ,pp. : 427-440

Informa Healthcare

Access to resources Recommend Favorite

Chromatin-modifying enzymes as therapeutic targets – Part 1

By Keppler Brian R Archer Trevor K

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 10, 2008-10 ,pp. : 1301-1312

Informa Healthcare

Access to resources Recommend Favorite

Lipogenic Enzymes as Therapeutic Targets for Obesity and Diabetes

Current Pharmaceutical Design, Vol. 17, Iss. 4, 2011-02 ,pp. : 325-331

Bentham Science Publishers

Access to resources Recommend Favorite